United States · Who invested in Epirus Biopharmaceuticals?
Epirus Biopharmaceuticals's investors include 5AM Ventures, Montreux Growth Partners, TPG, Adage Capital Management and Mousse Partners, and 3 more on record.
20132014
$8.1MVenture$5.0MVenture$36MSeries BUnited States · Series B startup
Who invested in Epirus Biopharmaceuticals
3 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$49Mraised across 3 rounds since 2012, from 3 sources
$8.1MVenture$5.0MVenture$36MSeries B
- Latest round
- Series B, $36MApr 2014
- Step-upi
- 7.2×
- Investors
- 8
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $8.1M Apr 2012
- Biggest round
- $36M Series B · Apr 2014
- Usual gap between rounds
- 21 months the median of 2
The rounds
- Apr 2014Series B$36M6 new2 returning
TPG
5AM Ventures- Adage Capital Management
Montreux Growth Partners
Mousse Partners
Livzon Mabpharm- Greenwoods Investment
- Gibralt US
From a historical funding record
- Jul 2012
- Apr 2012
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Venture2012Venture2012Series B20145AM VenturesMontreux Growth PartnersTPGAdage Capital ManagementMousse PartnersLivzon MabpharmGreenwoods InvestmentGibralt US
5AM VenturesMontreux Growth PartnersTPGAdage Capital ManagementMousse PartnersLivzon MabpharmGreenwoods InvestmentGibralt USEveryone who backed them
Adage Capital ManagementAsset manager1round
Greenwoods InvestmentGrowth equity1round
Gibralt USno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Epirus Biopharmaceuticals
How much has Epirus Biopharmaceuticals raised?
Epirus Biopharmaceuticals has raised $49M across 3 rounds since 2012.
When did Epirus Biopharmaceuticals last raise?
Epirus Biopharmaceuticals's most recent round was a Series B of $36M in Apr 2014.
What was Epirus Biopharmaceuticals's biggest round?
Its most recent round, $36M in Apr 2014, is also its largest on record.
Who backed Epirus Biopharmaceuticals first?
Epirus Biopharmaceuticals's first round on record, in Apr 2012, was backed by 5AM Ventures and Montreux Growth Partners.
What stage is Epirus Biopharmaceuticals at?
Epirus Biopharmaceuticals's latest named round is a Series B, in Apr 2014.
Where is Epirus Biopharmaceuticals based?
Epirus Biopharmaceuticals is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.